Continuous administration of a P450 aromatase inhibitor induces polycystic ovary syndrome with a metabolic and endocrine phenotype in female rats at adult age.
about
Scientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome.A Novel Letrozole Model Recapitulates Both the Reproductive and Metabolic Phenotypes of Polycystic Ovary Syndrome in Female Mice.Uncovering steroidopathy in women with autism: a latent class analysisThe characterization of obese polycystic ovary syndrome rat model suitable for exercise interventionOutcome analysis of aromatase inhibitor therapy to increase adult height in males with predicted short adult stature and/or rapid pubertal progress: a retrospective chart review.Neuroendocrine Regulation of MetabolismAcupuncture does not ameliorate metabolic disturbances in the P450 aromatase inhibitor-induced rat model of polycystic ovary syndrome.Adiponectin protects against development of metabolic disturbances in a PCOS mouse model.Effects of Exercise Intervention on Preventing Letrozole-Exposed Rats From Polycystic Ovary Syndrome.Up-Regulation of Long Noncoding RNA SRA Promotes Cell Growth, Inhibits Cell Apoptosis, and Induces Secretion of Estradiol and Progesterone in Ovarian Granular Cells of Mice.Immunohistochemical evaluation of proliferation, apoptosis and steroidogenic enzymes in the ovary of rats with polycystic ovary.Effect of combination of Withania somnifera Dunal and Tribulus terrestris Linn on letrozole induced polycystic ovarian syndrome in rats.Therapeutic potentials of Quercetin in management of polycystic ovarian syndrome using Letrozole induced rat model: a histological and a biochemical study.Oxidative stress and metabolic markers in pre- and postnatal polycystic ovary syndrome rat protocols.
P2860
Q28390200-0546839E-CCD6-446C-9E9C-3CC2E12505DFQ30356743-24E29DE0-E73E-4E0B-A01A-C4B358C5C30CQ33616148-05F74DC2-7771-4744-B2CA-C6EA75064598Q33721736-84D73ABF-A15A-47C9-BF2E-EC75301D17C3Q35835667-6B51977E-94C5-4B1A-885E-9566FBC526D2Q37116109-BB782176-CA95-4D08-A531-9B16942A3764Q47371510-6A5482CD-AD94-40E5-9CA3-CF652818D0BCQ48271377-A4511828-3369-48DB-9122-3B3B42F83F5FQ51281895-C039AABF-7DCD-4033-9559-4406BB5AEABDQ52718175-992AD3BB-716E-4797-9D4F-11DCD582428CQ53021060-3097718F-E119-427C-AB92-1D5E0EFBFF32Q53499282-934918B2-AD6F-443E-8C01-F5559B654EE0Q53698719-36304D42-ABD0-49FB-BB0B-D45959502076Q54943855-CA685803-FC8D-4208-B055-1C1E7F0648AA
P2860
Continuous administration of a P450 aromatase inhibitor induces polycystic ovary syndrome with a metabolic and endocrine phenotype in female rats at adult age.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Continuous administration of a ...... e in female rats at adult age.
@en
Continuous administration of a ...... e in female rats at adult age.
@nl
type
label
Continuous administration of a ...... e in female rats at adult age.
@en
Continuous administration of a ...... e in female rats at adult age.
@nl
prefLabel
Continuous administration of a ...... e in female rats at adult age.
@en
Continuous administration of a ...... e in female rats at adult age.
@nl
P2093
P356
P1433
P1476
Continuous administration of a ...... e in female rats at adult age.
@en
P2093
Anna Benrick
Antoni J Duleba
Fernand Labrie
Henrik Svensson
Julia Johansson
Malin Lönn
Manuel Maliqueo
P304
P356
10.1210/EN.2012-1693
P407
P577
2012-11-26T00:00:00Z